Sun-Novo
68862157.150.70% ( +0.40 )
Sun-Novo (688621)
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates...
- Open
- 57.00
- High
- 58.27
- Low
- 56.00
- Prev. Close
- 56.75
- Volume
- 15.10K
- Turnover
- 86.50M
- Avg Price
- 57.28
- Bid/Ask Ratio
- --
- Amplitude
- 4.00%
- 52wk High
- 86.31
- Volume Ratio
- 0.27
- Turnover Ratio
- 1.35%
Sun-Novo Analyst Rating
View MoreForecast & Rating
Jul 4, 2025Price forecast
¥75.0431.30%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Nov 3, 2025 at 02:40 AM
Sun-Novo: The first-instance judgment of the lawsuit requires Hang Seng Pharmaceutical to pay 2.4032 million yuan
- Zhitong · Oct 31, 2025 at 05:46 AM
Sun-Novo: Plans to acquire Langyan Life and increase its shareholding to over 30%
- Zhitong · Oct 19, 2025 at 02:37 AM
Sun-Novo plans to invest 15 million yuan in JiaoYuanMa ZhiYao
- Zhitong · Oct 12, 2025 at 03:34 AM
Sun-Novo: BTP4507 has received the notification of approval for clinical trials
- Zhitong · Sep 15, 2025 at 08:26 PM
Pacific Securities: The pharmaceutical industry is stabilizing and improving, with signs of recovery already visible
- Zhitong · Sep 14, 2025 at 09:47 PM
CRO concept fluctuates and strengthens, Boteng Co., Ltd. rises over 9%
